Atlas Trials

A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms

Clinical trial NCT03511768 · UNKNOWN

Trial details

NCT number
NCT03511768
Sponsor
Xiangya Hospital of Central South University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Neoplasm
Start date
2018-01-02
Primary completion
2019-12-30
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.